Cargando…

The Model of PPARγ-Downregulated Signaling in Psoriasis

Interactions of genes in intersecting signaling pathways, as well as environmental influences, are required for the development of psoriasis. Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor and transcription factor which inhibits the expression of many proinflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sobolev, Vladimir, Nesterova, Anastasia, Soboleva, Anna, Dvoriankova, Evgenia, Piruzyan, Anastas, Mildzikhova, Dzerassa, Korsunskaya, Irina, Svitich, Oxana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568796/ https://www.ncbi.nlm.nih.gov/pubmed/33133175 http://dx.doi.org/10.1155/2020/6529057

Ejemplares similares

Analysis of PPARγ Signaling Activity in Psoriasis
por: Sobolev, Vladimir, et al.
Publicado: (2021)

The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells
por: Sobolev, Vladimir V., et al.
Publicado: (2022)

Proteomic Studies of Psoriasis
por: Sobolev, Vladimir V., et al.
Publicado: (2022)

Differential Expression of Estrogen-Responsive Genes in Women with Psoriasis
por: Sobolev, Vladimir, et al.
Publicado: (2021)

LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing
por: Sobolev, V. V., et al.
Publicado: (2021)

Laser Therapy Changes the Expression of Matrix Metalloproteinases in Bleomycin-Induced Skin Fibrosis
por: Soboleva, Anna G., et al.
Publicado: (2023)

Study of Molecular Mechanisms Involved in the Pathogenesis of Immune-Mediated Inflammatory Diseases, using Psoriasis As a Model
por: Piruzian, E.S., et al.
Publicado: (2009)

Three-Dimensional Model of Mouse Epidermis for Experimental Studies of Psoriasis
por: Soboleva, A.G., et al.
Publicado: (2013)

Adipogenic differentiation was inhibited by downregulation of PPARγ signaling pathway in aging tendon stem/progenitor cells
por: Lai, Fan, et al.
Publicado: (2021)

Pharmacological Control of Receptor of Advanced Glycation End-Products and its Biological Effects in Psoriasis
por: Mezentsev, A. V., et al.
Publicado: (2013)

Glucose intolerance after chronic stress is related with downregulated PPAR-γ in adipose tissue
por: Pereira, Vitor H., et al.
Publicado: (2016)

MiR-19 Family Impairs Adipogenesis by the Downregulation of the PPARγ Transcriptional Network
por: Juiz-Valiña, Paula, et al.
Publicado: (2022)

Phillygenin inhibits the inflammation and apoptosis of pulmonary epithelial cells by activating PPARγ signaling via downregulation of MMP8
por: Lin, Yufeng, et al.
Publicado: (2021)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Rosiglitazone activation of PPARγ suppresses fractalkine signaling
por: Wan, Yihong, et al.
Publicado: (2010)

PPAR-γ Signaling Crosstalk in Mesenchymal Stem Cells
por: Takada, Ichiro, et al.
Publicado: (2010)

Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017)

The Interplay of WNT and PPARγ Signaling in Vascular Calcification
por: Reinhold, Stefan, et al.
Publicado: (2020)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation
por: Park, Chung-Hwa, et al.
Publicado: (2017)

TGF-β is insufficient to induce adipocyte state loss without concurrent PPARγ downregulation
por: Taylor, Brooks, et al.
Publicado: (2020)

Apigetrin inhibits adipogenesis in 3T3-L1 cells by downregulating PPARγ and CEBP-α
por: Hadrich, Fatma, et al.
Publicado: (2018)

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease
por: Govindarajulu, Manoj, et al.
Publicado: (2018)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
por: Rovito, Daniela, et al.
Publicado: (2016)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung
por: Rehan, Virender K., et al.
Publicado: (2012)

Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer
por: Sikka, Sakshi, et al.
Publicado: (2012)

Baicalin Promotes CNS Remyelination via PPARγ Signal Pathway
por: Ai, Ruo-Song, et al.
Publicado: (2022)

Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes
por: Piątkowska-Chmiel, Iwona, et al.
Publicado: (2022)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_elm2170si2d1k34egrafv5hhga